US2009118788A1PendingUtilityA1

Methods and apparatus for effectuating a lasting change in a neural-function of a patient

54
Assignee: NORTHSTAR NEUROSCIENCE INCPriority: Jul 13, 2000Filed: Jan 14, 2009Published: May 7, 2009
Est. expiryJul 13, 2020(expired)· nominal 20-yr term from priority
A61N 1/0534A61N 1/0539A61N 1/36025A61N 1/36082A61N 1/36017A61N 1/3756A61N 1/0531A61N 1/361
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure suggests methods of selecting a stimulation site for stimulating a patient's brain or methods of effectuating a neural-function of a patient associated with an impaired body function. In one exemplary implementation, such a neural function may be effectuated by selecting a stimulation site, positioning at least a first electrode at the stimulation site, and applying an electrical potential to pass a current through the first electrode. If one aspect, this stimulation site may be selected by a) identifying a second body function that is a corollary to the impaired body function, and b) determining a corollary location of the patient's brain that is associated with the second body function and is ipsilateral to the impaired body function.

Claims

exact text as granted — not AI-modified
1 - 32 . (canceled) 
     
     
         33 . A method for treating a patient, comprising:
 identifying a patient as suffering from a neurological dysfunction;   identifying one or more potential target neural populations by applying transcranial magnetic stimulation to the patient and monitoring the patient's response;   selecting a target neural population from the one or more potential target neural populations;   implanting a cortical surface electrode beneath the patient's skull, outside a cortical surface of the patient's bran and proximate to the target neural population; and   applying electrical signals to the target neural population via the electrode to address the patient's dysfunction.   
     
     
         34 . The method of  claim 33  wherein identifying a patient as suffering from a neurological dysfunction includes identifying the patient as suffering from depression. 
     
     
         35 . The method of  claim 33  wherein monitoring the patient's response includes monitoring the patient's performance of a mental process. 
     
     
         36 . The method of  claim 33  wherein monitoring the patient's response includes monitoring the patient's performance of a memorization task. 
     
     
         37 . The method of  claim 33  wherein monitoring the patient's response includes monitoring the patient's movement of a body part. 
     
     
         38 . The method of  claim 33  wherein selecting includes selecting the target neural population from among a plurality of potential target neural populations identified by applying transcranial magnetic stimulation to the patient. 
     
     
         39 . The method of  claim 33  wherein implanting a cortical surface electrode includes implanting a cortical surface electrode at a site ipsilateral to a body part impaired by the neural dysfunction, the body part being external to the patient's brain. 
     
     
         40 . The method of  claim 33  wherein implanting a cortical surface electrode includes implanting a cortical surface electrode at a site contralateral to a portion of the patient's brain adversely affected by the neurological dysfunction. 
     
     
         41 . The method of  claim 33  wherein applying electrical signals includes applying electrical signals at a subthreshold level for neurons at the target neural population. 
     
     
         42 . The method of  claim 33  wherein selecting a target neural population includes selecting a target neural population based at least in part on an expected neuroplastic activity related to a neurological function that is adversely affected by the patient's neurological dysfunction. 
     
     
         43 . The method of  claim 33  wherein applying electrical stimulation includes applying electrical stimulation to have an effect lasting for an extended period after the stimulation is halted. 
     
     
         44 . The method of  claim 33 , further comprising directing the patient to engage in an adjunctive therapy as part of a treatment regimen that includes applying the electrical signals to the target neural population. 
     
     
         45 . The method of  claim 44  wherein the adjunctive therapy includes a behavioral therapy. 
     
     
         46 . A method for treating a patient, comprising:
 identifying a patient as suffering from depression;   identifying one or more potential target neural populations by applying transcranial magnetic stimulation to the patient and monitoring the patient's response;   selecting a target neural population from the one or more potential target neural populations;   implanting an array of cortical surface electrodes beneath the patient's skull, outside a cortical surface of the patient's bran and proximate to the target neural population; and   applying electrical signals to the target neural population via the electrodes to address the patient's depression.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.